Next Article in Journal
Egyptian Blue into Carboxymetylcellulose: New Dual-Emissive Solid-State Luminescent Films
Previous Article in Journal
Regulation of Blood–Brain Barrier Permeability via JNK Signaling Pathway: Mechanisms and Potential Therapeutic Strategies for Ischemic Stroke, Alzheimer’s Disease and Brain Tumors
Previous Article in Special Issue
Synthesis of 1,4-Benzodiazepines via Intramolecular C–N Bond Coupling and Ring Opening of Azetidines
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis of Ethynyl Trifluoromethyl Sulfide and Its Application to the Synthesis of CF3S-Containing Triazoles

by
Alejandra Riesco-Domínguez
,
Hussein Hammoudeh
,
Daniel Blanco-Ania
and
Floris P. J. T. Rutjes
*
Institute for Molecules and Materials, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, The Netherlands
*
Author to whom correspondence should be addressed.
Molecules 2025, 30(11), 2358; https://doi.org/10.3390/molecules30112358
Submission received: 17 April 2025 / Revised: 20 May 2025 / Accepted: 24 May 2025 / Published: 28 May 2025
(This article belongs to the Special Issue Synthesis, Modification and Application of Heterocyclic Compounds)

Abstract

:
The unprecedented use of ethynyl trifluoromethyl sulfide (CF3S–C≡CH) as a synthetically useful building block has been described for the first time. It was reacted with various aromatic and aliphatic azides under copper-catalyzed conditions to yield a novel class of 1,4-disubstituted triazoles bearing the SCF3 group (15 examples, up to 86% yield).

Graphical Abstract

1. Introduction

The incorporation of the (trifluoromethyl)sulfanyl group (SCF3) into druglike molecules may significantly enhance their bioavailability and induce more effective transport through lipid membranes (Hansch parameter π = 1.44) [1,2]. Consequently, introducing the SCF3 group into organic molecules is relevant for agrochemical and pharmaceutical communities that focus on isostere-based drug design [3]. In this regard, synthetic chemists also aim at developing new pathways for the incorporation of this SCF3 substituent, hence contributing to discoveries in biomedical research [4]. A few analogs derived from biologically active compounds have been developed since the chemistry of the SCF3 group became more widespread (Figure 1). For example, the SCF3 group has been used as an isostere in losartan analogs, used clinically for the treatment of cardiovascular diseases [5]. Vaniliprole and JKU 0422 were developed as analogs of the insecticide fipronil, a compound with a trifluoromethyl sulfoxide [6]. Finally, a methionine analog was also developed, which is of interest for peptide design because of the strong steric and electrostatic properties of the CF3 group [7].
The use of chemical building blocks represents one of the major strategies of the pharmaceutical and agrochemical industries for the construction of compound libraries. Thus, the discovery of new CF3S-containing building blocks that can be utilized for the synthesis of potentially biologically active molecules represents an important focus for organic chemists nowadays. In this regard, the majority of known building blocks bearing the SCF3 group consist of either (hetero)aromatic or disubstituted vinylic/acetylenic molecules [8,9,10,11]. Surprisingly, however, the synthesis of the parent building blocks CF3S-ethene/acetylene (2 and 3) and their application to prepare heterocycles are unexplored. We have reported the synthesis of the trifluoromethyl vinyl sulfide building block 2 from chloro alkane 1 and its application to the synthesis of a new class of isoxazolidines 4 by 1,3-dipolar cycloaddition reactions with nitrones (Scheme 1) [12]. The inherent potential of building block 2 [13] motivated us to study the synthesis of its CF3S-acetylene counterpart 3 as well. Thus, we report herein the first synthesis of ethynyl trifluoromethyl sulfide 3 [14] and its use as a building block for the synthesis of drug-like CF3S-containing 1,4-disubstituted triazoles 5 (Scheme 1).

2. Results and Discussion

The synthesis of CF3S–C≡CH (3) started with the preparation of trifluoromethyl vinyl sulfide 2 from commercially available chloro alkane 1 (Scheme 2).
We applied the conditions reported by us (1.3 equiv of KOtBu, 1.0 M solution in THF) [12] to afford alkene 2 quantitatively. Then, bromine was added to the solution containing alkene 2 [15]. Initial experiments showed that the addition of 2.0 equiv of Br2 gave full conversion to dibromide 6, but that 4-bromobutan-1-ol was also formed as a side product from the reaction of bromine with THF [16,17]. We therefore replaced THF with CH2Cl2 (except for the stock solution of KOtBu in THF) and reduced the amount of Br2 to avoid side product formation. Alkene 2 was then prepared from chloro alkane 1 in CH2Cl2 (KOtBu, 1.3 equiv), with full conversion under these conditions. The subsequent addition of Br2 (1.1 equiv) afforded dibromide 6 with full conversion and without side products (Scheme 2). We tried to isolate dibromide 6 by distillation, but these attempts resulted in the decomposition of 6 when evaporating the solvent.
Finally, the last steps of the synthesis of CF3S–C≡CH (3) implied a double elimination reaction of dibromide 6 (Table 1). It is worth noting that compounds 2, 6, 7 and 3 were not isolated and that the reactions were followed in all cases by 1H and 19F NMR. Preliminary studies using 1,2-dibromoethyl phenyl sulfide as a model substrate showed that KOtBu, NaOH and NaNH2 (in excess) were not suitable bases for both eliminations to occur. After screening several other bases, we concluded that the combination of KOtBu and NaHMDS gave the best results (Table 1).
The reaction of dibromide 6 with NaHMDS (2.0 equiv, entry 1) afforded bromo alkene 7 with full conversion after 17 h of reaction time. The addition of one more equivalent revealed the disappearance of alkene 7 by 1H NMR. Assuming that alkyne 3 was formed in the reaction, and based on previous results from our research group that revealed the importance of high pressure to promote the cycloaddition reaction of alkene 2 with nitrones [12], 1-azido-4-nitrobenzene was added and the reaction mixture was brought under 15 kbar of pressure [18,19,20]. Unfortunately, no product was obtained and the starting azide was recovered, so we continued investigating the formation of alkyne 3. We repeated the same procedure, confirming that alkene 7 was formed after 1.5 h and with the addition of 2.0 equiv of NaHMDS (entry 2). Unfortunately, the addition of one further equivalent of NaHMDS did not result in the formation of alkyne 3. When we used KOtBu as the base for the first elimination (1.5 equiv, entry 3), we observed the formation of not only alkene 7 but also alkyne 3 (ratio 7/3 4:1). The subsequent addition of NaHMDS (0.6 equiv) increased the formation of alkyne 3, even though alkene 7 was still present in the reaction mixture. When we used KOtBu and NaHMDS (1.3 and 0.7 equiv, respectively; entry 4), an increase in alkyne 3 was obtained. Finally, the best result was obtained by employing KOtBu (1.3 equiv) and a subsequent excess of NaHMDS (1.7 equiv), providing alkyne 3 as the sole product in the reaction mixture (entry 5).
With CF3S–C≡CH (3) in hand, we focused our attention on the azide–alkyne cycloaddition reaction [21,22,23,24,25,26,27] for the synthesis of 1,4-disubstituted triazoles (5) bearing the SCF3 group [28]. Triazoles are some of the most exploited structures in heterocyclic chemistry because their structural motif occurs in products with a diversity of biological activity, such as antiviral, analgesic, anti-inflammatory, anticonvulsant, antimicrobial and anticancer effects [29,30,31,32].
Following the same strategy described by us for the synthesis of CF3S-containing isoxazolidines [12], we studied the high-pressure-promoted synthesis of CF3S-containing 1,4-disubstituted triazoles 5 (Table 2).
We first performed the reaction of azide 8a (R = NO2) and CF3S–C≡CH (3) at 21 °C under 15 kbar of pressure (entry 1). Promisingly, the reaction proceeded smoothly and, after 72 h reaction time, we isolated triazole 5a in a 78% yield. Surprisingly, compound 5a was the only regioisomer formed [33], representing the first non-catalyzed regioselective azide–alkyne 1,3-dipolar cycloaddition reported in the literature. Azide 8a, however, did not show any conversion into the desired triazole 5a under thermal conditions (30 °C; entry 2) for 72 h. Initially, we refrained from using higher temperatures because of the volatility of CF3S–C≡CH (3). The reaction times for azides 8b (R = F, entry 3) and 8c (R = CF3, entry 4) were longer (120 h led to 2:7 and 4:7 ratios for 5b/8b and 5c/8c, respectively) and the yields were rather low (49% and 38%, respectively), even when heated up to 50 °C. Applying the same reaction conditions to substrates 8d (R = Me, entry 5) and 8e (R = OMe, entry 6), the ratios of 5d/8d and 5e/8e were 1:6 and 1:15, respectively, after 120 h of reaction time. As a result, we decided to perform the synthesis of triazoles 5 under copper-catalyzed conditions. Thus, the cycloaddition of azide 8a with CF3S–C≡CH (3), CuSO4·5H2O (0.01 equiv), sodium ascorbate (0.02 equiv) and benzoic acid (0.1 equiv), in a mixture of tBuOH/H2O/CH2Cl2 at 30 °C, afforded triazole 5a after 16 h in an 82% yield (entry 7). Compound 5b was isolated in an 85% yield when using azide 8b (R = F) under copper-catalyzed conditions at 60 °C (entry 8). These conditions greatly improved the results as compared to the high-pressure-promoted reactions and reduced the reaction times considerably.
Various azides were examined in the copper-catalyzed azide–alkyne cycloaddition reaction [34] by employing the conditions shown in entries 7 and 8 of Table 2. We used commercially available azides (8bg, 8n and 8o) and freshly synthesized azides 8a and 8hm (using the corresponding aniline under the classical conditions [35]: NaNO2 and TsOH followed by reaction with NaN3; see Section 3.2) as substrates. A total of 12 aromatic azides (8al) with electron-donating or electron-withdrawing groups at the 2-, 3- and 4-positions were used to study the scope of the copper-catalyzed cycloaddition reaction with CF3S–C≡CH (3; Scheme 3). These reactions proceeded at different temperatures and reaction times and in varying yields (all isolated yields) depending on the position and electronic effect of the aryl substituents of azides 8al. The yields were moderate to very good (61–86%; 5ad, 5f, 5g and 5l), except when the phenyl ring was substituted with a MeO or CN group (5e, 5h5k). Most of the azides reacted at 50 °C, yielding triazoles 5c, 5e and 5hl. Compounds 5a, 5f and 5g were formed at 30 °C, whereas triazoles 5b and 5d required 60 and 70 °C, respectively.
The reaction times also varied with the substrate. The majority of the reactions were carried out for 48 h (compounds 5d, 5f and 5hl), whereas the reaction rates were accelerated (16 h) for compounds 5ac and 5g. For compounds 5e, 5h and 5j, bearing a methoxy substituent at the 4-, 3- and 2-positions of the phenyl ring, we identified the formation of the corresponding 1,5-disubstituted regioisomers by NMR analysis (1H, 13C and HSQC) in 1,4/1,5 ratios of 10:1 (for compounds 5h and 5j) and 12:1 (for compound 5e) [36,37,38].
Finally, we expanded the scope of this reaction to the synthesis of heteroaromatic and aliphatic CF3S-containing triazoles (Scheme 3). In this manner, we were able to synthesize pyridinyl triazole 5m after 16 h of reaction time at 70 °C in a 65% yield. Moreover, aliphatic triazoles (5n and 5o) were synthesized in good yields (62 and 70%) at 50 °C for 16 h (Scheme 3).

3. Materials and Methods

3.1. Reagents and Equipment

Reagents were obtained from commercial suppliers and were used without purification. Standard syringe techniques were applied for the transfer of dry solvents and air- or moisture-sensitive reagents. Reactions were followed, and RF values were obtained, using thin layer chromatography (TLC) on silica gel-coated plates (Merck 60 F254) with the indicated solvent mixture. Detection was performed with UV light and/or by charring at ca. 150 °C after dipping into a solution of either 2% anisaldehyde in ethanol/H2SO4, KMnO4 or ninhydrin. Infrared spectra were recorded on an IR-ATR Bruker TENSOR 27 spectrometer. High-resolution or accurate mass measurements (ΔM < 3 mmu or 5 ppm) were recorded on a JEOL AccuTOF-CS JMS-T100CS for electrospray (spectra recorded in infusion in MeOH containing 50nM PPG-475 as internal mass-drift compensation standard) or a JEOL AccuTOF-GCv JMS-T100GCv (GC/electron ionization MS, column bleeding at high temperature used as internal mass drift compensation standard). NMR spectra (see Supplementary Materials) were recorded at 298 K on a Varian Inova 400 (400 MHz), Bruker Avance III 400 MHz or Bruker Avance III 500 MHz spectrometer in the solvent indicated. Chemical shifts are given in parts per million (ppm) with respect to tetramethylsilane (0.00 ppm) as an internal standard for 1H NMR and to CDCl3 (77.16 ppm) as an internal standard for 13C NMR. Coupling constants are reported as J values in hertz (Hz). 1H NMR data are reported as follows: chemical shift (ppm), multiplicity (s = singlet, d = doublet, dd = doublet of doublets, dt = doublet of triplets, ddd = doublet of doublet of doublets, dtdq = doublet of triplet of doublet of quartets, dq = doublet of quartets, ddd = doublet of doublet of doublets, ddt = doublet of doublets of triplets, dddd = doublet of doublets of doublets of doublets, ddquint = doublet of doublet of quintets, dddquint = doublet of doublet of doublet of quintets, quint = quintet, t = triplet, td = triplet of doublets, tt = triplet of triplets, m = multiplet, b = broad), coupling constants (Hz), integration and assignment. Compounds were fully characterized by 1H and 13C spectra and 2D COSY, HSQC, HMBC, NOESY and HOESY spectra. Column or flash chromatography was carried out using ACROS silica gel (0.035–0.070 mm, 60 Å pore diameter).

3.2. General Procedure for the Synthesis of Aromatic Azides 8h–k

The corresponding aniline 9hk (1.0 mmol; Scheme 4) was added to a solution of TsOH·H2O (1.62 g, 9.0 mmol) in H2O (9 mL). After stirring for 1 min, anhydrous NaNO2 (0.621 g, 9.0 mmol) was added gradually over 5 min. The resulting solution was then stirred for a period between 2 and 60 min until the starting amine disappeared (reactions were monitored by TLC). Anhydrous NaN3 (0.104 g, 1.6 mmol) was added to the resulting solution, and the immediate emission of N2 was observed. The solid aromatic azides (8h and 8i) were filtered off, washed with H2O (50 mL) and dried in vacuo, whereas the oily azides (8j and 8k) were extracted with AcOEt (3 × 10 mL) and dried over Na2SO4. The suspension was filtered off and dried under reduced pressure.

3.2.1. 1-Azido-3-methoxybenzene (8h) [39]

According to the general procedure, the reaction of aniline 9h (123 mg, 1.0 mmol) afforded azide 8h (144.7 mg, 0.97 mmol). 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.25 (t, J = 8.1 Hz, 1 H), 6.67 (ddd, J = 8.3, 2.4, 0.8 Hz, 1 H), 6.65 (ddd, J = 8.0, 2.1, 0.9 Hz, 1 H), 6.55 (t, J = 2.2 Hz, 1 H), 3.80 (s, 3 H). Yield: 97%.

3.2.2. 3-Azidobenzonitrile (8i) [40]

According to the general procedure, the reaction of aniline 9i (118.1 mg, 1.0 mmol) afforded azide 8i (136.9 mg, 0.95 mmol). 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.65–7.56 (m, 2 H), 7.28–7.25 (m, 1 H), 7.22 (td, J = 7.7, 1.0 Hz, 1 H). Yield: 95%.

3.2.3. 1-Azido-2-methoxybenzene (8j) [39]

According to the general procedure, the reaction of aniline 9j (123.2 mg, 1.0 mmol) afforded azide 8j (141.7 mg, 0.95 mmol). 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.10 (td, J = 7.8, 1.7 Hz, 1 H), 7.02 (dd, J = 7.8, 1.7 Hz, 1 H), 6.97–6.88 (m, 2 H), 3.88 (s, 3 H, OCH3). Yield: 95%.

3.2.4. 2-Azidobenzonitrile (8k) [41]

According to the general procedure, the reaction of aniline 9k (118.1 mg, 1.0 mmol) afforded azide 8k (115.3 mg, 0.80 mmol). 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.50–7.40 (m, 2 H), 7.30–7.24 (m, 2 H). Yield: 80%.
Azides 8bg were commercially available, and azides 8a [35], 8l [42] and 8m [43] were previously prepared in our research group according to procedures published in the literature.

3.3. General Procedure for the Synthesis of Ethynyl Trifluoromethyl Sulfide (3)

In a sealed vial under a nitrogen atmosphere, 2-chloroethyl trifluoromethyl sulfide (1; 100 mg, 0.608 mmol) was dissolved in CH2Cl2 (1 mL). The solution was cooled to 0 °C and subsequently KOtBu (790 µL, 0.790 mmol, 1.3 equiv, 1.0 M solution in THF) was slowly added. The reaction mixture was stirred at 21 °C for 90 min to form trifluoromethyl vinyl sulfide (2). Then, Br2 (34 µL, 107 mg, 0.668 mmol, 1.1 equiv) in CH2Cl2 (1 mL) was added at 21 °C to the solution containing alkene 2. The reaction mixture was stirred for 1 h, until the orange color of the mixture changed to a pale-yellow color, to afford the CF3S-dibromo derivative 6. Subsequently, the mixture was filtered and the CH2Cl2 was evaporated under reduced pressure to reduce the volume of the mixture by 50%. The reaction mixture was then cooled to 0 °C, KOtBu (790 µL, 0.790 mmol, 1.3 equiv, 1.0 M solution in THF) was slowly added, and the reaction mixture was stirred at 21 °C for 90 min to afford alkene 7. Finally, NaHMDS (517 µL, 1.034 mmol, 1.7 equiv, 2.0 M solution in THF) was slowly added and the mixture stirred for 1 h to give CF3S–C≡CH (3). 1H NMR and 19F NMR were checked after every reaction step and used for the final characterization of CF3S–C≡CH (3).

3.3.1. Trifluoromethyl Vinyl Sulfide (2) [12]

1H NMR [400 MHz, δ (ppm), THF-d8]: 6.54 (dd, J = 16.5, 9.4 Hz, 1 H, 1-CH), 5.72 (dq, J = 9.4, 1.5 Hz, 1 H, 2-CHa), 5.70 (d, J = 16.5, 1 H, 2-CHb). 13C NMR [101 MHz, δ (ppm), THF-d8]: 129.8 (q, J = 306.5 Hz, SCF3), 124.4 (q, J = 1.0 Hz, 2-C), 121.3 (q, J = 3.2 Hz, 1-C). 19F NMR [377 MHz, δ (ppm), THF-d8]: −43.6.

3.3.2. 1,2-Dibromoethyl Trifluoromethyl Sulfide (6)

1H NMR [400 MHz, δ (ppm), CDCl3]: 5.46 (dd, J = 7.1, 5.7 Hz, 1 H, 1-CH), 4.00 (ddq, J = 11.4, 5.8, 0.5 Hz, 1 H, 2-CHH), 3.91 (ddq, J = 11.4, 7.1, 0.6 Hz, 1 H, 2-CHH). 13C NMR [126 MHz, δ (ppm), CD2Cl2/THF-d8]: 130.37 (q, J = 309.1 Hz, SCF3), 48.3 (1-C), 37.0 (2-C). 19F NMR [377 MHz, δ (ppm), CDCl3]: −40.9.

3.3.3. 1-Bromovinyl Trifluoromethyl Sulfide (7)

1H NMR [500 MHz, δ (ppm), CD2Cl2/THF-d8]: 6.56 (d, J = 2.3 Hz, 1 H, 2-CHH), 6.41 (dq, J = 2.3, 0.8 Hz, 1 H, 2-CHH). 13C NMR [126 MHz, δ (ppm), CD2Cl2/THF-d8]: 138.2 (q, J = 1.3 Hz, 2-C), 130.0 (d, J = 310.5 Hz, SCF3), 112.3 (q, J = 2.9 Hz, 1-C). 19F NMR [377 MHz, δ (ppm), CDCl3]: −42.5.

3.3.4. Ethynyl Trifluoromethyl Sulfide (3)

1H NMR [400 MHz, δ (ppm), CDCl3]: 3.33 (s, 1 H, CH). 19F NMR [377 MHz, δ (ppm), CDCl3]: −43.2.

3.4. General Procedure for the Synthesis of 1,4-Disubstituted-1H-1,2,3-Triazoles 5a–o

A solution containing a mixture of CF3S–C≡CH (3; 3.0 equiv) and the corresponding azide 8 (1.0 equiv) in CH2Cl2/THF was added to a solution of CuSO4·5H2O (2.5 mg, 0.01 mmol), sodium ascorbate (4 mg, 0.02 mmol) and benzoic acid (12 mg, 0.1 mmol) in tBuOH/H2O (1:2 v/v, 1.0 mL) in a 4 mL vial. Then, CH2Cl2 was added in order to fill the vial completely. The resultant mixture was stirred for the stated time at the indicated temperature for every reaction (reactions were followed by 1H and 19F NMR). The reaction mixture was then quenched with H2O (20 mL) and extracted with CH2Cl2 (3 × 15 mL). The combined organic layers were washed with H2O and brine, dried over anhydrous Na2SO4, filtered off and concentrated in vacuo. The crude product was purified by column chromatography (heptane/AcOEt, 4:1) to afford the corresponding triazoles 5ap.

3.4.1. 1-(4-Nitrophenyl)-4-[(trifluoromethyl)sulfanyl]-1H-1,2,3-triazole (5a)

According to the general procedure, the reaction of 1-azido-4-nitrobenzene 8a (21 mg, 0.13 mmol) with CF3S–C≡CH (3) at 30 °C for 16 h afforded triazole 5a (46.4 mg, 0.16 mmol) as a yellow–brown solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: δ 8.51–8.44 (m, 2 H, 3-CH + 5-CH), 8.42 (s, 1 H, CH), 8.05–7.98 (m, 2 H, 2-CH + 6-CH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 148.0 (4-C), 140.5 (1-C), 132.0 (C–S, indirect observation), 128.33 (CH), 128.32 (q, J = 310.0 Hz, SCF3), 125.9 (3-C + 5-C), 121.1 (2-C + 6-C).19F NMR [377 MHz, δ (ppm), CDCl3]: −42.5. FTIR [ ν ¯ (cm−1)]: 2924, 1599, 1519, 1348, 1144, 1102, 907, 733. RF: 0.32 (heptane/AcOEt, 4:1). Yield: 82%.

3.4.2. 1-(4-Fluorophenyl)-4-[(trifluoromethyl)sulfanyl]-1H-1,2,3-triazole (5b)

According to the general procedure, the reaction of 1-azido-4-fluorobenzene 8b (250 µL, 0.125 mmol, 0.5 M solution in tBuOMe) with CF3S–C≡CH (3) at 60 °C for 16 h afforded triazole 5b (28.0 mg, 0.106 mmol) as a brown solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.26 (s, 1 H, CH), 7.79–7.67 (m, 2 H, 2-CH + 6-CH), 7.31–7.22 (m, 2 H, 3-CH + 5-CH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 163.1 (d, J = 250.6 Hz, 4-C), 132.7 (1-C), 130.8 (C–S), 128.6 (CH), 128.4 (q, J = 309.7 Hz, SCF3), 123.0 (d, J = 8.8 Hz, 2-C + 6-C), 117.2 (d, J = 23.5 Hz, 3-C + 5-C). 19F NMR [377 MHz, δ (ppm), CDCl3]: −42.7 (SCF3). FTIR [ ν ¯ (cm−1)]: 3125, 1520, 1243, 1146, 1122, 839. HRMS [ESI (m/z)] calcd for (C9H5F4N3S + H)+ = 264.02186, found 264.02227 (|Δ| = 1.59 ppm). RF: 0.42 (heptane/AcOEt, 4:1). Yield: 85%.

3.4.3. 1-[4-(Trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfanyl]-1H-1,2,3-triazole (5c)

According to the general procedure, the reaction of 1-azido-4-(trifluoromethyl)benzene 8c (250 µL, 0.125 mmol, 0.5 M solution in tBuOMe) with CF3S–C≡CH (3) at 50 °C for 16 h afforded triazole 5c (31.3 mg, 0.10 mmol) as a yellow solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.38 (s, 1 H, CH), 7.97–7.89 (m, 2 H, 2-CH + 6-CH), 7.88–7.82 (m, 2 H, 3-CH + 5-CH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 138.8 (1-C), 131.9 (q, J = 33.4 Hz, 4-C), 131.4 (C–S), 128.37 (q, J = 309.9 Hz, SCF3), 128.37 (CH), 127.5 (q, J = 3.7 Hz, 3-C + 5-C), 123.5 (q, J = 272.4 Hz, CF3), 120.9 (2-C + 6-C). 19F NMR [377 MHz, δ (ppm), CDCl3]: −42.6 (SCF3), −62.8 (CF3). FTIR [ ν ¯ (cm−1)]: 3117, 1335, 1151, 1106, 844. HRMS [ESI (m/z)] calcd for (C10H5F6N3S + H)+ = 314.01866, found 314.02077 (|Δ| = 2.11 mmu). RF: 0.50 (heptane/AcOEt, 4:1). Yield: 80%.

3.4.4. 1-(4-Methylphenyl)-4-[(trifluoromethyl)sulfanyl]-1H-1,2,3-triazole (5d)

According to the general procedure, the reaction of 1-azido-4-methylbenzene 8d (250 µL, 0.125 mmol, 0.5 M solution in tBuOMe) with CF3S–C≡CH (3) at 70 °C for 48 h afforded triazole 5d (28.0 mg, 0.108 mmol) as a brown solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.26 (s, 1 H, CH), 7.64–7.59 (m, 2 H, 2-CH + 6-CH), 7.38–7.32 (m, 2 H, 3-CH + 5-CH), 2.44 (s, 3 H, CH3). 13C NMR [101 MHz, δ (ppm), CDCl3]: 140.1 (4-C), 134.2 (1-C), 130.6 (3-C + 5-C), 130.3 (C–S), 128.46 (q, J = 309.7 Hz, SCF3), 128.45 (CH), 120.7 (2-C + 6-C), 21.3 (CH3). 19F NMR [377 MHz, δ (ppm), CDCl3]: −42.8. FTIR [ ν ¯ (cm−1)]: 2967, 1143, 1119, 1039, 817. HRMS [ESI (m/z)] calcd for (C10H8F3N3S + H)+ = 260.04693, found 260.04638 (|Δ| = 2.11 ppm). RF: 0.44 (heptane/AcOEt, 4:1). Yield: 86%. Compound 5d could not be isolated in pure form after column chromatography.

3.4.5. 1-(4-Methoxyphenyl)-4-[(trifluoromethyl)sulfanyl]-1H-1,2,3-triazole (5e)

According to the general procedure, the reaction of 1-azido-4-methoxybenzene 8e (250 µL, 0.125 mmol, 0.5 M solution in tBuOMe) with CF3S–C≡CH (3) at 50 °C for 72 h afforded a 12:1 mixture of 1,4-/1,5-disubstituted triazole 5e (7.0 mg, 0.025 mmol) as a yellow–brown solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.21 (s, 1 H, CH), 7.67–7.62 (m, 2 H, 2-CH + 6-CH), 7.10–7.01 (m, 2 H, 3-CH + 5-CH), 3.89 (s, 3 H, OCH3). 13C NMR [101 MHz, δ (ppm), CDCl3]: 160.5 (4-C), 130.1 (1-C), 129.7 (C–S), 128.4 (CH), 128.3 (q, J = 309.6 Hz, SCF3), 122.4 (2-C + 6-C), 115.0 (3-C + 5-C), 55.7 (OCH3). 19F NMR [377 MHz, δ (ppm), CDCl3]: −42.8. FTIR [ ν ¯ (cm−1)]: 2926, 1522, 1261, 1145, 1121, 830. HRMS [ESI (m/z)] calcd for (C10H8F3N3OS + H)+ = 276.04184, found 276.04126 (|Δ| = 2.11 ppm). RF: 0.32 (heptane/AcOEt, 4:1). Yield: 20%. The ratio between the corresponding 1,4- and 1,5-regioisomers was not determined from the crude mixtures but from the corresponding purified fractions.

3.4.6. 1-Phenyl-4-[(trifluoromethyl)sulfanyl]-1H-1,2,3-triazole (5f)

According to the general procedure, the reaction of phenyl azide 8f (250 µL, 0.125 mmol, 0.5 M solution in tBuOMe) with CF3S–C≡CH (3) at 30 °C for 48 h afforded triazole 5f (22.4 mg, 0.09 mmol) as a brown solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.30 (s, 1 H, CH), 7.78–7.73 (m, 2 H, 2-CH + 6-CH), 7.61–7.55 (m, 2 H, 3-CH + 5-CH), 7.54–7.48 (m, 1 H, 4-CH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 136.2 (1-C), 130.5 (C–S, indirect observation), 130.2 (3-C + 5-C), 129.8 (4-C), 128.5 (CH), 120.9 (2-C + 6-C). The carbon signal of SCF3 was not observed. 19F NMR [377 MHz, δ (ppm), CDCl3]: −42.8. FTIR [ ν ¯ (cm−1)]: 2989, 1141, 1120, 1041, 758. HRMS [ESI (m/z)] calcd for (C9H6F3N3S + H)+ = 246.03128, found 246.03124 (|Δ| = 0.15 ppm). RF: 0.36 (heptane/AcOEt, 4:1). Yield: 73%.

3.4.7. 1-(3-Chlorophenyl)-4-[(trifluoromethyl)sulfanyl]-1H-1,2,3-triazole (5g)

According to the general procedure, the reaction of 1-azido-3-chlorobenzene 8g (200 µL, 0.10 mmol, 0.5 M solution in tBuOMe) with CF3S–C≡CH (3) at 30 °C for 16 h afforded triazole 5g (21.0 mg, 0.075 mmol) as a brown solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.32 (s, 1 H, CH), 7.81 (td, J = 1.9, 0.6 Hz, 1 H, 2-CH), 7.67 (dt, J = 7.4, 2.0 Hz, 1 H, 6-CH), 7.53 (t, J = 7.7 Hz, 1 H, 5-CH), 7.48 (dt, J = 8.1, 1.8 Hz, 1 H, 4-CH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 137.2 (1-C or 3-C), 136.1 (1-C or 3-C), 131.2 (5-C), 131.0 (C–S), 129.9 (4-C), 128.43 (CH), 128.39 (q, J = 309.8 Hz, SCF3), 121.1 (2-C), 118.8 (6-C). 19F NMR [377 MHz, δ (ppm), CDCl3]: −42.7. FTIR [ ν ¯ (cm−1)]: 3124, 1597, 1155, 1118, 1040, 784. HRMS [ESI (m/z)] calcd for (C9H5F3N3SCl + H)+ = 279.99231, found 279.99238 (|Δ| = 0.26 ppm). RF: 0.40 (heptane/AcOEt, 4:1). Yield: 75%.

3.4.8. 1-(3-Methoxyphenyl)-4-[(trifluoromethyl)sulfanyl]-1H-1,2,3-triazole (5h)

According to the general procedure, the reaction of 1-azido-3-methoxybenzene 8h (19 mg, 0.13 mmol) with CF3S–C≡CH (3) at 50 °C for 48 h afforded a 10:1 mixture of 1,4-/1,5-disubstituted triazole 5h (12.9 mg, 0.047 mmol) as a brown solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.28 (s, 1 H, CH), 7.45 (t, J = 8.2 Hz, 1 H, 5-CH), 7.35 (t, J = 2.3 Hz, 1 H, 2-CH), 7.28 (ddd, J = 8.2, 2.1, 0.9 Hz, 1 H, 6-CH), 7.03 (ddd, J = 8.2, 2.6, 0.9 Hz, 1 H, 4-CH), 3.90 (s, 3 H, OCH3). 13C NMR [101 MHz, δ (ppm), CDCl3]: 160.9 (3-C), 137.5 (1-C), 130.9 (5-C), 130.4 (C–S), 128.6 (CH), 128.5 (q, J = 309.6 Hz, SCF3), 115.6 (4-C), 112.6 (6-C), 106.7 (2-C), 55.9 (OCH3). 19F NMR [377 MHz, δ (ppm), CDCl3]: −42.8. FTIR [ ν ¯ (cm−1)]: 2932, 1612, 1146, 1110, 1032. HRMS [ESI (m/z)] calcd for (C10H8F3N3OS + H)+ = 276.04184, found 276.04185 (|Δ| = 0.03 ppm). RF: 0.34 (heptane/AcOEt, 4:1). Yield: 36%. The ratio between the corresponding 1,4- and 1,5-regioisomers was not determined from the crude mixtures but from the corresponding purified fractions.

3.4.9. 3-{4-[(Trifluoromethyl)sulfanyl]-1H-1,2,3-triazol-1-yl}benzonitrile (5i)

According to the general procedure, the reaction of 3-azidobenzonitrile 8i (20 mg, 0.14 mmol) with CF3S–C≡CH (3) at 50 °C for 48 h afforded triazole 5i (15.1 mg, 0.056 mmol) as a brown solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.35 (s, 1 H, CH), 8.10 (t, J = 1.9 Hz, 1 H, 2-CH), 8.05 (ddd, J = 8.1, 2.3, 1.2 Hz, 1 H, 4-CH), 7.81 (dt, J = 7.8, 1.3 Hz, 1 H, 6-CH), 7.73 (t, J = 7.9 Hz, 1 H, 5-CH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 137.0 (3-C), 133.1 (6-C), 131.36 (5-C), 131.34 (C–S), 128.2 (CH), 124.8 (4-C), 124.0 (2-C), 117.1 (CN), 114.7 (1-C). The carbon signal of SCF3 was not observed. 19F NMR [377 MHz, δ (ppm), CDCl3]: −42.5. FTIR [ ν ¯ (cm−1)]: 2930, 2235, 1109, 1032, 755. RF: 0.17 (heptane/AcOEt, 4:1). Yield: 40%.

3.4.10. 1-(2-Methoxyphenyl)-4-[(trifluoromethyl)sulfanyl]-1H-1,2,3-triazole (5j)

According to the general procedure, the reaction of 1-azido-2-methoxybenzene 8j (19 mg, 0.13 mmol) with CF3S–C≡CH (3) at 50 °C for 48 h afforded a 10:1 mixture of 1,4-/1,5-disubstituted triazole 5j (11.0 mg, 0.04 mmol) as a brown solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.48 (s, 1 H, CH), 7.86 (dd, J = 7.9, 1.7 Hz, 1 H, 6-CH), 7.47 (ddd, J = 8.3, 7.6, 1.7 Hz, 1 H, 4-CH), 7.17–7.10 (m, 2 H, 3-CH + 5-CH), 3.93 (s, 3 H, OCH3). 13C NMR [101 MHz, δ (ppm), CDCl3]: 150.8 (2-C), 132.4 (CH), 130.8 (4-C), 128.8 (C–S), 128.4 (q, J = 309.7 Hz, SCF3), 125.6 (1-C), 125.1 (6-C), 121.4 (5-C), 112.3 (3-C), 56.1 (OCH3). 19F NMR [377 MHz, δ (ppm), CDCl3]: −43.1. FTIR [ ν ¯ (cm−1)]: 2939, 1604, 1510, 1285, 1256, 1106, 1026, 754. HRMS [ESI (m/z)] calcd for (C10H8F3N3OS + H)+ = 276.04184, found 276.04158 (|Δ| = 0.93 ppm). RF: 0.38 (heptane/AcOEt, 4:1). Yield: 31%. The ratio between the corresponding 1,4- and 1,5-regioisomers was not determined from the crude mixtures but from the corresponding purified fractions.

3.4.11. 2-{4-[(Trifluoromethyl)sulfanyl]-1H-1,2,3-triazol-1-yl}benzonitrile (5k)

According to the general procedure, the reaction of 2-azidobenzonitrile 8k (18 mg, 0.12 mmol) with CF3S–C≡CH (3) at 50 °C for 48 h afforded triazole 5k (9.7 mg, 0.036 mmol) as a brown solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.59 (s, 1 H, CH), 7.95 (dd, J = 8.2, 1.2 Hz, 1 H, 3-CH), 7.91 (dd, J = 7.8, 1.5 Hz, 1 H, 6-CH), 7.87 (td, J = 7.8, 1.5 Hz, 1 H, 4-CH), 7.68 (td, J = 7.7, 1.3 Hz, 1 H, 5-CH).13C NMR [101 MHz, δ (ppm), CDCl3]: 137.8 (2-C), 134.8 (4-C), 134.6 (6-C), 131.0 (C–S, indirect observation), 130.8 (CH), 130.5 (5-C), 128.4 (q, J = 309.9 Hz, SCF3), 125.7 (3-C), 115.3 (CN), 106.9 (1-C). 19F NMR [377 MHz, δ (ppm), CDCl3]: −42.6. FTIR [ ν ¯ (cm−1)]: 2923, 2853, 1520, 1349, 1146, 1103, 1034, 853. HRMS [ESI (m/z)] calcd for (C10H5F3N4S + H)+ = 271.02653, found 271.02598 (|Δ| = 2.00 ppm). RF: 0.14 (heptane/AcOEt, 4:1). Yield: 30%.

3.4.12. 1-(2,6-Difluorophenyl)-4-[(trifluoromethyl)sulfanyl]-1H-1,2,3-triazole (5l)

According to the general procedure, the reaction of 2-azido-1,3-difluorobenzene 8l (21 mg, 0.14 mmol) with CF3S–C≡CH (3) at 50 °C for 48 h afforded triazole 5l (23.9 mg, 0.085 mmol) as a brown solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 8.18 (s, 1 H, CH), 7.55 (tt, J = 8.6, 6.0 Hz, 1 H, 4-CH), 7.22–7.14 (m, 2 H, 3-CH + 5-CH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 156.8 (dd, J = 257.5, 2.7 Hz, 2-C + 6-C), 133.0 (CH), 132.3 (t, J = 9.7 Hz, 4-CH), 130.0 (C–S), 128.37 (q, J = 309.7 Hz, SCF3), 113.0–112.7 (m, 3-C + 5-C). The signal of 1-C was not observed. 19F NMR [377 MHz, δ (ppm), CDCl3]: −42.82 (SCF3). FTIR [ ν ¯ (cm−1)]: 2919, 1480, 1111, 1032, 1014, 788. HRMS [ESI (m/z)] calcd for (C9H4F5N3S + H)+ = 282.01243, found 282.01226 (|Δ| = 0.63 ppm). RF: 0.21 (heptane/AcOEt, 4:1). Yield: 61%.

3.4.13. 4-{4-[(Trifluoromethyl)sulfanyl]-1H-1,2,3-triazol-1-yl}pyridine (5m)

According to the general procedure, the reaction of 4-azidopyridine 8m (19 mg, 0.16 mmol) with CF3S–C≡CH (3) at 70 °C for 16 h afforded triazole 5m (25.6 mg, 0.104 mmol) as a brown solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 9.10–8.60 (m, 2 H, 2-CH + 6-CH), 8.44 (s, 1 H, CH), 7.79–7.72 (m, 2 H, 3-CH + 5-CH). 13C NMR [101 MHz, δ (ppm), CDCl3]: 150.9 (2-C + 6-C), 141.4 (4-C), 130.7 (C–S), 127.2 (q, J = 310.0 Hz, SCF3), 126.7 (CH), 112.8 (3-C + 5-C). 19F NMR [377 MHz, δ (ppm), CDCl3]: −42.5. FTIR [ ν ¯ (cm−1)]: 3113, 1587, 1510, 1150, 1111, 1037, 845, 706. RF: 0.12 (heptane/AcOEt, 4:1). Yield: 65%.

3.4.14. 1-Benzyl-4-[(trifluoromethyl)sulfanyl]-1H-1,2,3-triazole (5n)

According to the general procedure, the reaction of (azidomethyl)benzene 8n (22 mg, 0.17 mmol) with CF3S–C≡CH (3) at 50 °C for 16 h afforded triazole 5n (27.2 mg, 0.105 mmol) as a brown solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.76 (s, 1 H, CH), 7.44–7.37 (m, 3 H, 3-CH + 4-CH + 5-CH), 7.31–7.27 (m, 2 H, 2-CH + 6-CH), 5.58 (s, 2 H, NCH2). 13C NMR [101 MHz, δ (ppm), CDCl3]: 133.7 (1-C), 130.3 (C–S), 130.2 (CH), 129.5 (3-C + 5-C), 129.4 (4-C), 128.42 (q, J = 309.5 Hz, SCF3), 128.37 (2-C + 6-C), 54.9 (NCH2). 19F NMR [377 MHz, δ (ppm), CDCl3]: −43.0. FTIR [ ν ¯ (cm−1)]: 2362, 1984, 1143, 1129, 1044, 716. HRMS [ESI (m/z)] calcd for (C10H8F3N3S + H)+ = 260.04693, found 260.04899 (|Δ| = 2.06 mmu). RF: 0.28 (heptane/AcOEt, 4:1). Yield: 62%.

3.4.15. 1-(Adamantan-1-yl)-4-[(trifluoromethyl)sulfanyl]-1H-1,2,3-triazole (5o)

According to the general procedure, the reaction of 1-azidoadamantane 8o (22 mg, 0.12 mmol) with CF3S–C≡CH (3) at 50 °C for 16 h afforded triazole 5o (26.2 mg, 0.09 mmol) as a pale solid. 1H NMR [400 MHz, δ (ppm), CDCl3]: 7.90 (s, 1 H, CH), 2.32–2.23 (m, 9 H, adamantyl), 1.88–1.75 (m, 6 H, adamantyl). 13C NMR [101 MHz, δ (ppm), CDCl3]: 128.4 (q, J = 309.0 Hz, SCF3), 128.2 (C–S), 126.9 (CH), 60.9 (1-C), 42.8 (2-C), 35.8 (4-C), 29.4 (3-C). 19F NMR [377 MHz, δ (ppm), CDCl3]: −43.2. FTIR [ ν ¯ (cm−1)]: 2915, 1140, 1109, 1019. HRMS [ESI (m/z)] calcd for (C13H16F3N3S + H)+ = 304.10953, found 304.11024 (|Δ| = 0.71 mmu). RF: 0.48 (heptane/AcOEt, 4:1). Yield: 70%.

4. Conclusions

In summary, we have developed the first method for the synthesis of ethynyl trifluoromethyl sulfide 3 as the major product, a building block for the synthesis of CF3S-containing heterocycles. This method involves one-pot three-step synthesis, which was directly applied to synthesize CF3S-containing triazoles via copper-catalyzed 1,3-dipolar cycloaddition reactions with several (hetero)aromatic and aliphatic azides. Currently, the biological properties of these compounds are being evaluated in various assays, and the reactivity of the CF3S–C≡CH (3) is being further explored with different dipoles.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules30112358/s1. Scheme S1: Synthesis of aromatic azides 8hk from anilines 9hk; S2–S20: Dates of NMR of Compounds. References [12,35,39,40,41,42,43,44,45] are cited in the Supplementary Materials.

Author Contributions

Conceptualization, A.R.-D., D.B.-A. and F.P.J.T.R.; methodology, A.R.-D., D.B.-A. and F.P.J.T.R.; validation, A.R.-D., D.B.-A. and F.P.J.T.R.; formal analysis, A.R.-D., H.H. and D.B.-A.; investigation, A.R.-D. and H.H.; resources, F.P.J.T.R.; data curation, A.R.-D. and H.H.; writing—original draft preparation, A.R.-D.; writing—review and editing, A.R.-D., D.B.-A. and F.P.J.T.R.; visualization, A.R.-D., D.B.-A. and F.P.J.T.R.; supervision, D.B.-A. and F.P.J.T.R.; project administration, A.R.-D., D.B.-A. and F.P.J.T.R.; funding acquisition, F.P.J.T.R. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by FP7Marie Curie Actions of the European Commission via the ITN ECHONET Network (MCITN-2012-316379).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are contained within the article.

Conflicts of Interest

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of the data; in the writing of the manuscript; or in the decision to publish the results.

Abbreviations

The following abbreviations are used in this manuscript:
THFTetrahydrofuran
HMDS1,1,1,3,3,3-Hexamethyldisilazanide
AscAscorbate
NMRNuclear magnetic resonance
HSQCHeteronuclear single quantum correlation
HMBCHeteronuclear multiple bond correlation
NOESYNuclear Overhauser effect spectroscopy
HOESYHeteronuclear Overhauser effect spectroscopy

References

  1. Zhou, J.; Zhang, Q.F.; Zhao, W.H.; Jiang, G.F. Chiral phosphoric acid-catalyzed asymmetric transfer hydrogenation of 3-trifluoromethylthioquinolines. Org. Biomol. Chem. 2016, 14, 6937–6941. [Google Scholar] [CrossRef] [PubMed]
  2. Bootwicha, T.; Liu, X.; Pluta, R.; Atodiresei, I.; Rueping, M. N-Trifluoromethylthiophthalimide: A stable electrophilic SCF3-reagent and its application in the catalytic asymmetrictrifluoromethylsulfenylation. Angew. Chem. Int. Ed. 2013, 52, 12856–12859. [Google Scholar] [CrossRef] [PubMed]
  3. Shao, X.; Wang, X.; Yang, T.; Lu, L.; Shen, Q. An electrophilic hypervalent iodine reagent for trifluoromethylthiolation. Angew. Chem. Int. Ed. 2013, 52, 3457–3460. [Google Scholar] [CrossRef] [PubMed]
  4. Yoshida, M.; Kawai, K.; Tanaka, R.; Yoshino, T.; Matsunaga, S. Cp*CoIII-catalyzed directed C–H trifluoromethylthiolation of 2-phenylpyridines and 6-arylpurines. Chem. Commun. 2017, 53, 5974–5977. [Google Scholar] [CrossRef]
  5. Yagupolskii, L.M.; Maletina, I.I.; Petko, K.I.; Fedyuk, D.V.; Handrock, R.; Shavaran, S.S.; Klebanov, B.M.; Herzig, S. New fluorine-containing hypotensive preparations. J. Fluor. Chem. 2001, 109, 87–94. [Google Scholar] [CrossRef]
  6. Leroux, F.; Jeschke, P.; Schlosser, M. α-Fluorinated ethers, thioethers, and amines: Anomerically biased species. Chem. Rev. 2005, 105, 827–856. [Google Scholar] [CrossRef]
  7. Sorochinsky, A.E.; Ueki, H.; Aceña, J.L.; Ellis, T.K.; Moriwaki, H.; Sato, T.; Soloshonok, V.A. Chemical deracemization and (S) to (R) interconversion of some fluorine-containing α-amino acids. J. Fluor. Chem. 2013, 152, 114–118. [Google Scholar] [CrossRef]
  8. Xu, C.; Ma, B.; Shen, Q. N-Trifluoromethylthiosaccharin: An easily accessible, shelf-stable, broadly applicable trifluoromethylthiolating reagent. Angew. Chem. Int. Ed. 2014, 53, 9316–9320. [Google Scholar] [CrossRef]
  9. Pluta, R.; Nikolaienko, P.; Rueping, M. Direct catalytic trifluoromethylthiolation of boronic acids and alkynes employing electrophilic shelf-stable N-(trifluoromethylthio)phthalimide. Angew. Chem. Int. Ed. 2014, 53, 1650–1653. [Google Scholar] [CrossRef]
  10. Alazet, S.; Zimmer, L.; Billard, T. Base-catalyzed electrophilic trifluoromethylthiolation of terminal alkynes. Angew. Chem. Int. Ed. 2013, 52, 10814–10817. [Google Scholar] [CrossRef]
  11. Cheng, Y.-X.; Yang, X.-G.; Du, F.-H.; Zhang, C. Direct trifluoromethylthiolation of terminal alkynes mediated by a hypervalent trifluoromethylthio-iodine(III) reagent; boosting effect of fluorinated alcohol. Green Chem. 2024, 26, 5914–5920. [Google Scholar] [CrossRef]
  12. Riesco-Domínguez, A.; van de Wiel, J.; Hamlin, T.A.; van Beek, B.; Lindell, S.D.; Blanco-Ania, D.; Bickelhaupt, F.M.; Rutjes, F.P.J.T. Trifluoromethyl vinyl sulfide: A building block for the synthesis of CF3S-containing isoxazolidines. J. Org. Chem. 2018, 83, 1779–1789. [Google Scholar] [CrossRef] [PubMed]
  13. Sokolenko, L.V.; Maletina, I.I.; Yagupolskii, L.M.; Yagupolskii, Y.L. A convenient and efficient synthesis of trifluoromethyl vinyl sulfoxide and its reactivity in addition reactions. Synlett 2010, 2010, 2075–2078. [Google Scholar] [CrossRef]
  14. Harris, J.F., Jr.; Joyce, R.M., Jr. Ethynyl Trifluoromethyl Sulfide 3 Was Detected as a Side Product of the Synthesis of bis(trifluoromethylsulfanyl)acetylene. Fluoroalkylthioacetylenes. U.S. Patent 3062893, 6 November 1962. [Google Scholar]
  15. Harris, J.F., Jr. Trifluoromethylthioalkanes, -olefins, and -acetylenes. J. Org. Chem. 1967, 32, 2063–2074. [Google Scholar] [CrossRef]
  16. Lo, J.M.H.; Marriott, R.A.; Giri, B.R.; Roscoe, J.M.; Klobukowski, M. A theoretical analysis of the kinetics of the reaction of atomic bromine with tetrahydrofuran. Can. J. Chem. 2010, 88, 1136–1145. [Google Scholar] [CrossRef]
  17. Giri, B.R.; Roscoe, J.M. Temperature dependence of the rate coefficients for the reactions of atomic bromine with toluene, tetrahydrofuran, and tetrahydropyran. J. Phys. Chem. A 2009, 113, 8001–8010. [Google Scholar] [CrossRef] [PubMed]
  18. Blanco-Ania, D.; Aben, R.W.M.; van Berkom, L.W.A.; Scheeren, H.W.; Rutjes, F.P.J.T. Synthesis of steroidal D-ring-fused pyrrolidines of dehydroepiandrosterone. Eur. J. Org. Chem. 2017, 2017, 3729–3737. [Google Scholar] [CrossRef]
  19. Blanco-Ania, D.; Aben, R.W.M.; van Berkom, L.W.A.; Scheeren, H.W.; Rutjes, F.P.J.T. High-pressure-mediated extension of the privileged steroid scaffold. Eur. J. Org. Chem. 2014, 2014, 1438–1444. [Google Scholar] [CrossRef]
  20. Jenner, G. Correlation between pressure and steric interactions in organic reactions. Tetrahedron 2005, 61, 3621–3635. [Google Scholar] [CrossRef]
  21. Singh, M.S.; Chowdhury, S.; Koley, S. Advances of azide-alkyne cycloaddition-click chemistry over the recent decade. Tetrahedron 2016, 72, 5257–5283. [Google Scholar] [CrossRef]
  22. Thirumurugan, P.; Matosiuk, D.; Jozwiak, K. Click chemistry for drug development and diverse chemical–biology applications. Chem. Rev. 2013, 113, 4905–4979. [Google Scholar] [CrossRef] [PubMed]
  23. Kolb, H.C.; Finn, M.G.; Sharpless, K.B. Click chemistry: Chemical function from a few good reactions. Angew. Chem. Int. Ed. 2001, 40, 2004–2021. [Google Scholar] [CrossRef]
  24. Meldal, M.; Tornøe, C.W. Cu-catalyzed azide–alkyne cycloaddition. Chem. Rev. 2008, 108, 2952–3015. [Google Scholar] [CrossRef] [PubMed]
  25. Haldon, E.; Nicasio, M.C.; Perez, P. Copper-catalysed azide–alkyne cycloadditions (CuAAC): An update. J. Org. Biomol. Chem. 2015, 13, 9528–9550. [Google Scholar] [CrossRef]
  26. Rostovtsev, V.V.; Green, L.G.; Fokin, V.V.; Sharpless, K.B. A stepwise Huisgen cycloaddition process: Copper(I)-catalyzed regioselective “ligation” of azides and terminal alkynes. Angew. Chem. Int. Ed. 2002, 41, 2596–2599. [Google Scholar] [CrossRef]
  27. Vale, D.P.; Vala, R.M.; Patel, H.M. Versatile synthetic platform for 1,2,3-triazole chemistry. ACS Omega 2022, 7, 36945–36987. [Google Scholar] [CrossRef]
  28. Zhang, L.L.; Li, M.T.; Shen, L.L.; Wu, Q.P. Efficient synthesis of 5-trifluoromethylthio-1,2,3-triazoles: One-pot multicomponent reaction from elemental sulfur and TMSCF3. Synthesis 2020, 52, 304–310. [Google Scholar] [CrossRef]
  29. Alcaide, B.; Almendros, P.; Lázaro-Milla, C. Metal-free [3+2] cycloaddition of azides with Tf2C=CH2 for the regioselective preparation of elusive 4-(trifluoromethylsulfonyl)-1,2,3-triazoles. Chem. Commun. 2015, 51, 6992–6995. [Google Scholar] [CrossRef]
  30. Ötvös, S.B.; Fülöp, F. Flow chemistry as a versatile tool for the synthesis of triazoles. Catal. Sci. Technol. 2015, 5, 4926–4941. [Google Scholar] [CrossRef]
  31. Baumann, M.; Baxendale, I.R.; Ley, S.V.; Nikbin, N. An overview of the key routes to the best selling 5-membered ring heterocyclic pharmaceuticals. Beilstein J. Org. Chem. 2011, 7, 442–495. [Google Scholar] [CrossRef]
  32. Agalave, S.G.; Maujan, S.R.; Pore, V.S. Click chemistry: 1,2,3-Triazoles as pharmacophores. Chem. Asian J. 2011, 6, 2696–2718. [Google Scholar] [CrossRef] [PubMed]
  33. Tietze, L.F.; Steck, P.L. High Pressure in Organic Synthesis: Influence on Selectivity. In High Pressure Chemistry; van Eldik, R., Klärner, F.G., Eds.; Wiley-VCH: Weinheim, Germany, 2002; pp. 239–283. [Google Scholar]
  34. Shao, C.; Wang, X.; Xu, J.; Zhao, J.; Zhang, Q.; Hu, Y. Carboxylic acid-promoted copper(I)-catalyzed azide–alkyne cycloaddition. J. Org. Chem. 2010, 75, 7002–7005. [Google Scholar] [CrossRef] [PubMed]
  35. Kutonova, K.V.; Trusova, M.E.; Postnikov, P.S.; Filimonov, V.D.; Parello, J. A simple and effective synthesis of aryl azides via arenediazonium tosylates. Synthesis 2013, 45, 2706–2710. [Google Scholar]
  36. Blastik, Z.E.; Voltrová, S.; Matoušek, V.; Jurásek, B.; Manley, D.W.; Klepetářová, B.; Beier, P. Azidoperfluoroalkanes: Synthesis and application in copper(I)-catalyzed azide–alkyne cycloaddition. Angew. Chem. Int. Ed. 2017, 56, 346–349. [Google Scholar] [CrossRef] [PubMed]
  37. Lakshman, M.K.; Singh, M.K.; Parrish, D.; Balachandran, R.; Day, B.W. Azide–tetrazole equilibrium of C-6 azidopurine nucleosides and their ligation reactions with alkynes. J. Org. Chem. 2010, 75, 2461–2473. [Google Scholar] [CrossRef]
  38. Song, W.; Zheng, N.; Li, M.; He, J.; Li, J.; Dong, K.; Ullah, K.; Zheng, Y. Rhodium(I)-catalyzed regioselective azi-internal alkynyl trifluoromethyl sulfide cycloaddition and azide-internal thioalkyne cycloaddition under mild conditions. Adv. Synth. Catal. 2019, 361, 469–475. [Google Scholar] [CrossRef]
  39. Kwok, S.W.; Fotsing, J.R.; Fraser, R.J.; Rodionov, V.O.; Fokin, V.V. Transition-metal-free catalytic synthesis of 1,5-diaryl-1,2,3-triazoles. Org. Lett. 2010, 12, 4217–4219. [Google Scholar] [CrossRef]
  40. Akula, H.K.; Lakshman, M.K. Synthesis of deuterated 1,2,3-triazoles. J. Org. Chem. 2012, 77, 8896–8904. [Google Scholar] [CrossRef]
  41. Budruev, A.V.; Dzhons, D.Y.; Faerman, V.I.; Fukin, G.K.; Shavyrin, A.S. Photochemical synthesis of 6-substituted 12-oxo-6,12-dihydroazepino [2,1-c]quinazolines. Chem. Heterocycl. Compd. 2016, 52, 694–699. [Google Scholar] [CrossRef]
  42. Jin, L.M.; Xu, X.; Lu, H.; Cui, X.; Wojtas, L.; Zhang, X.P. Effective synthesis of chiral N-fluoroaryl aziridines through enantioselective aziridination of alkenes with fluoroaryl azides. Angew. Chem. Int. Ed. 2013, 52, 5309–5313. [Google Scholar] [CrossRef]
  43. Colombano, G.; Travelli, C.; Galli, U.; Caldarelli, A.; Chini, M.G.; Canonico, P.L.; Sorba, G.; Bifulco, G.; Tron, G.C.; Genazzani, A.A. A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry. J. Med. Chem. 2010, 53, 616–623. [Google Scholar] [CrossRef] [PubMed]
  44. Bertrand, H.C.; Schaap, M.; Baird, L.; Georgakopoulos, N.D.; Fowkes, A.; Thiollier, C.; Kachi, H.; Dinkova-Kostova, A.T.; Wells, G. Design, Synthesis, and Evaluation of Triazole Derivatives That Induce Nrf2 Dependent Gene Products and Inhibit the Keap1-Nrf2 Protein-Protein Interaction. J. Med. Chem. 2015, 58, 7186. [Google Scholar] [CrossRef] [PubMed]
  45. Lanke, S.R.; Bhanage, B.M. Copper bis(2,2,6,6-Tetramethyl-3,5-heptanedionate)–Catalyzed Coupling of Sodium Azide with Aryl Iodides/Boronic Acids to Aryl Azides or Aryl Amines. Synth. Commun. 2014, 44, 399. [Google Scholar] [CrossRef]
Figure 1. CF3S-containing analogs derived from biologically active compounds.
Figure 1. CF3S-containing analogs derived from biologically active compounds.
Molecules 30 02358 g001
Scheme 1. Synthesis of CF3S-containing isoxazolidines 4 and triazoles 5 from chloro alkane 1.
Scheme 1. Synthesis of CF3S-containing isoxazolidines 4 and triazoles 5 from chloro alkane 1.
Molecules 30 02358 sch001
Scheme 2. Synthesis of dibromide 6 from chloro alkane 1.
Scheme 2. Synthesis of dibromide 6 from chloro alkane 1.
Molecules 30 02358 sch002
Scheme 3. Scope of the copper-catalyzed cycloaddition reaction of azides 8ao and CF3S–C≡CH (3).
Scheme 3. Scope of the copper-catalyzed cycloaddition reaction of azides 8ao and CF3S–C≡CH (3).
Molecules 30 02358 sch003
Scheme 4. Synthesis of aromatic azides 8hk from anilines 9hk.
Scheme 4. Synthesis of aromatic azides 8hk from anilines 9hk.
Molecules 30 02358 sch004
Table 1. Synthesis of CF3S-acetylene 3 from dibromide 6.
Table 1. Synthesis of CF3S-acetylene 3 from dibromide 6.
Molecules 30 02358 i001
EntryBaseEquivTime (h)Ratio 7/3 1
1NaHMDS2.0
then 1.0
17
2
1:0
disappearance of 7
2NaHMDS2.0
then 1.0
1.5
8
1:0
1:0
3KOtBu
then NaHMDS
1.5
0.6
1.5
1
4:1
1:0.9
4KOtBu
then NaHMDS
1.3
0.7
1.5
1
7:3
4:13
5KOtBu
then NaHMDS
1.3
1.7
1.5
1.5
4:1
0:1
1 Calculated by integration of the 1H NMR signals.
Table 2. Optimization process for the synthesis of CF3S-containing 1,4-disubstituted triazoles 5. 1.
Table 2. Optimization process for the synthesis of CF3S-containing 1,4-disubstituted triazoles 5. 1.
Molecules 30 02358 i002
EntrySubstrateRt (°C)Time (h)PromoterProductYield (%) 2
1 38aNO2217215 kbar5a78 4
28aNO221 → 30725a
38bF21 → 50 512015 kbar5b49
48cCF321 → 50 512015 kbar5c38
58dMe21 → 50 612015 kbar5d
68eOMe21 → 50 612015 kbar5e
78aNO23016Cu(I) 75a82
88bF6016Cu(I) 75b85
1 The synthesis of CF3S–C≡CH (3) was performed by using a mixture of KOtBu (1.3 equiv) and NaHMDS (1.7 equiv). 2 Isolated yield. 3 Reaction performed in THF. 4 4-Nitroaniline was obtained as a side product. 5 Reactions were performed at 21 °C for 96 h and at 50 °C for 24 h. 6 Reactions were performed at 21 °C for 72 h and at 50 °C for 48 h. 7 Reactions were performed with CuSO4·5H2O (0.01 equiv), sodium ascorbate (0.02 equiv), benzoic acid (0.1 equiv) in tBuOH/H2O (1:2).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Riesco-Domínguez, A.; Hammoudeh, H.; Blanco-Ania, D.; Rutjes, F.P.J.T. Synthesis of Ethynyl Trifluoromethyl Sulfide and Its Application to the Synthesis of CF3S-Containing Triazoles. Molecules 2025, 30, 2358. https://doi.org/10.3390/molecules30112358

AMA Style

Riesco-Domínguez A, Hammoudeh H, Blanco-Ania D, Rutjes FPJT. Synthesis of Ethynyl Trifluoromethyl Sulfide and Its Application to the Synthesis of CF3S-Containing Triazoles. Molecules. 2025; 30(11):2358. https://doi.org/10.3390/molecules30112358

Chicago/Turabian Style

Riesco-Domínguez, Alejandra, Hussein Hammoudeh, Daniel Blanco-Ania, and Floris P. J. T. Rutjes. 2025. "Synthesis of Ethynyl Trifluoromethyl Sulfide and Its Application to the Synthesis of CF3S-Containing Triazoles" Molecules 30, no. 11: 2358. https://doi.org/10.3390/molecules30112358

APA Style

Riesco-Domínguez, A., Hammoudeh, H., Blanco-Ania, D., & Rutjes, F. P. J. T. (2025). Synthesis of Ethynyl Trifluoromethyl Sulfide and Its Application to the Synthesis of CF3S-Containing Triazoles. Molecules, 30(11), 2358. https://doi.org/10.3390/molecules30112358

Article Metrics

Back to TopTop